Petra Tomše1, Luka Jensterle1, Marko Grmek1, Katja Zaletel1, Zvezdan Pirtošek2, Vijay Dhawan3, Shichun Peng3, David Eidelberg3, Yilong Ma3, Maja Trošt4. 1. Department of Nuclear Medicine, University Medical Centre Ljubljana, Ljubljana, Slovenia. 2. Department of Neurology, University Medical Centre Ljubljana, Zaloška cesta 2, 1000 Ljubljana, Slovenia. 3. Center for Neurosciences, The Feinstein Institute for Medical Research, Manhasset, NY, USA. 4. Department of Neurology, University Medical Centre Ljubljana, Zaloška cesta 2, 1000 Ljubljana, Slovenia. maja.trost@kclj.si.
Abstract
PURPOSE: The purpose of this study was to identify the specific metabolic brain pattern characteristic for Parkinson's disease (PD): Parkinson's disease-related pattern (PDRP), using network analysis of [18F]-fluorodeoxyglucose positron emission tomography (FDG-PET) brain images in a cohort of Slovenian PD patients. METHODS: Twenty PD patients (age 70.1 ± 7.8 years, Movement Disorder Society Unified Parkinson's Disease Motor Rating Scale (MDS-UPDRS-III) 38.3 ± 12.2; disease duration 4.3 ± 4.1 years) and 20 age-matched normal controls (NCs) underwent FDG-PET brain imaging. An automatic voxel-based scaled subprofile model/principal component analysis (SSM/PCA) was applied to these scans for PDRP-Slovenia identification. RESULTS: The pattern was characterized by relative hypermetabolism in pallidum, putamen, thalamus, brain stem, and cerebellum associated with hypometabolism in sensorimotor cortex, posterior parietal, occipital, and frontal cortices. The expression of PDRP-Slovenia discriminated PD patients from NCs (p < 0.0001) and correlated positively with patients' clinical score (MDS-UPDRS-III, p = 0.03). Additionally, its topography agrees well with the original PDRP (p < 0.001) identified in American cohort of PD patients. We validated the PDRP-Slovenia expression on additional FDG-PET scans of 20 PD patients, 20 NCs, and 25 patients with atypical parkinsonism (AP). We confirmed that the expression of PDRP-Slovenia manifests good diagnostic accuracy with specificity and sensitivity of 85-90% at optimal pattern expression cutoff for discrimination of PD patients and NCs and is not expressed in AP. CONCLUSION: PDRP-Slovenia proves to be a robust and reproducible functional imaging biomarker independent of patient population. It accurately differentiates PD patients from NCs and AP and correlates well with the clinical measure of PD progression.
PURPOSE: The purpose of this study was to identify the specific metabolic brain pattern characteristic for Parkinson's disease (PD): Parkinson's disease-related pattern (PDRP), using network analysis of [18F]-fluorodeoxyglucose positron emission tomography (FDG-PET) brain images in a cohort of Slovenian PDpatients. METHODS: Twenty PDpatients (age 70.1 ± 7.8 years, Movement Disorder Society Unified Parkinson's Disease Motor Rating Scale (MDS-UPDRS-III) 38.3 ± 12.2; disease duration 4.3 ± 4.1 years) and 20 age-matched normal controls (NCs) underwent FDG-PET brain imaging. An automatic voxel-based scaled subprofile model/principal component analysis (SSM/PCA) was applied to these scans for PDRP-Slovenia identification. RESULTS: The pattern was characterized by relative hypermetabolism in pallidum, putamen, thalamus, brain stem, and cerebellum associated with hypometabolism in sensorimotor cortex, posterior parietal, occipital, and frontal cortices. The expression of PDRP-Slovenia discriminated PDpatients from NCs (p < 0.0001) and correlated positively with patients' clinical score (MDS-UPDRS-III, p = 0.03). Additionally, its topography agrees well with the original PDRP (p < 0.001) identified in American cohort of PDpatients. We validated the PDRP-Slovenia expression on additional FDG-PET scans of 20 PDpatients, 20 NCs, and 25 patients with atypical parkinsonism (AP). We confirmed that the expression of PDRP-Slovenia manifests good diagnostic accuracy with specificity and sensitivity of 85-90% at optimal pattern expression cutoff for discrimination of PDpatients and NCs and is not expressed in AP. CONCLUSION: PDRP-Slovenia proves to be a robust and reproducible functional imaging biomarker independent of patient population. It accurately differentiates PDpatients from NCs and AP and correlates well with the clinical measure of PD progression.
Entities:
Keywords:
Atypical parkinsonism; FDG-PET; Parkinson’s disease; Principal component analysis; Specific metabolic brain network
Authors: Gene E Alexander; Kewei Chen; Melaney Aschenbrenner; Tricia L Merkley; Laura E Santerre-Lemmon; Jul Lea Shamy; William E Skaggs; Michael H Buonocore; Peter R Rapp; Carol A Barnes Journal: J Neurosci Date: 2008-03-12 Impact factor: 6.167
Authors: R Hilker; A V Thomas; J C Klein; S Weisenbach; E Kalbe; L Burghaus; A H Jacobs; K Herholz; W D Heiss Journal: Neurology Date: 2005-12-13 Impact factor: 9.910
Authors: Per Borghammer; Søren B Hansen; Carsten Eggers; Mallar Chakravarty; Kim Vang; Joel Aanerud; Rüdiger Hilker; Wolf-Dieter Heiss; Anders Rodell; Ole L Munk; David Keator; Albert Gjedde Journal: Acta Neurol Scand Date: 2011-06-21 Impact factor: 3.209
Authors: Olga Pletnikova; Neva West; Michael K Lee; Gay L Rudow; Richard L Skolasky; Ted M Dawson; Laura Marsh; Juan C Troncoso Journal: Neurobiol Aging Date: 2004-12-28 Impact factor: 4.673
Authors: Kaitlin L Bergfield; Krista D Hanson; Kewei Chen; Stefan J Teipel; Harald Hampel; Stanley I Rapoport; James R Moeller; Gene E Alexander Journal: Neuroimage Date: 2009-09-28 Impact factor: 6.556
Authors: Vincent Pozorski; Jennifer M Oh; Nagesh Adluru; Andrew P Merluzzi; Frances Theisen; Ozioma Okonkwo; Amy Barzgari; Stephanie Krislov; Jitka Sojkova; Barbara B Bendlin; Sterling C Johnson; Andrew L Alexander; Catherine L Gallagher Journal: Hum Brain Mapp Date: 2018-06-27 Impact factor: 5.038
Authors: Rafael Rodriguez-Rojas; Jose A Pineda-Pardo; Raul Martinez-Fernandez; Rosalie V Kogan; Carlos A Sanchez-Catasus; Marta Del Alamo; Frida Hernández; Lina García-Cañamaque; Klaus L Leenders; Jose A Obeso Journal: Eur J Nucl Med Mol Imaging Date: 2019-11-08 Impact factor: 9.236
Authors: Petra Tomše; Luka Jensterle; Sebastijan Rep; Marko Grmek; Katja Zaletel; David Eidelberg; Vijay Dhawan; Yilong Ma; Maja Trošt Journal: Phys Med Date: 2017-02-07 Impact factor: 2.685
Authors: Matej Perovnik; Petra Tomše; Jan Jamšek; Andreja Emeršič; Chris Tang; David Eidelberg; Maja Trošt Journal: Sci Rep Date: 2022-07-11 Impact factor: 4.996